Abstract
Hematopoietic stem cell transplantation (HSCT) is the only curative treatment available to severe thalassemic patients. The treatment, however, is very costly, particularly in the context of low and middle income countries, and no studies have been carried out to explore its economic justifiability. This study aimed to estimate the cost-utility of HSCT compared with blood transfusions combined with iron chelating therapy (BT-ICT) for severe thalassemia in Thailand, and to investigate the affordability of HSCT using a budget impact analysis. A Markov model was used to estimate the relevant costs and health outcomes over the patients' lifetimes taking a societal perspective as recommended by Thailand's health technology assessment guidelines. All future costs and outcomes were discounted at a rate of 3% per annum. Primary outcomes of interest were lifetime costs, quality adjusted life years (QALYs) gained, and the incremental cost-effectiveness ratio (ICER) in Thai baht (THB) per QALY gained. Compared to BT-ICT, the incremental cost-effectiveness ratio increased with patient age from 80,700 to 183,000 THB per QALY gained for related HSCT and 209,000 to 953,000 THB per QALY gained for unrelated HSCT among patients aged 1 to 15 yea...Continue Reading
References
Mar 1, 1994·Health Economics·A BriggsM Buxton
Mar 24, 1994·The New England Journal of Medicine·J O Armitage
Sep 21, 2000·British Journal of Haematology·S ChiodiA Bacigalupo
Sep 25, 2001·Blood·C KollmanD L Confer
May 31, 2002·Blood·Giorgio La NasaLicinio Contu
Jan 25, 2003·British Journal of Haematology·Sarah E LawsonPhilip J Darbyshire
Dec 17, 2003·Bone Marrow Transplantation·S HongengS Jootar
Feb 3, 2004·American Journal of Infection Control·Judith Morrison, UNKNOWN Health Canada, Nosocomial and Occupational Infections Section
Dec 1, 2004·The Hematology Journal : the Official Journal of the European Haematology Association·Mehran KarimiPiero C Giordano
Dec 13, 2005·Annals of the New York Academy of Sciences·Javid GazievGuido Lucarelli
Feb 24, 2006·Health Economics·Mark J SculpherChris McCabe
Jun 2, 2006·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Suradej HongengSaengsuree Jootar
Nov 23, 2006·Transplantation Proceedings·A Yildirim
Jan 31, 2007·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Yot TeerawattananonViroj Tangcharoensathien
Feb 27, 2007·Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine·Michelle H Biros, UNKNOWN Society for Academic Emergency Medicine
Jun 28, 2007·Clinical Oral Implants Research·J Mark ThomasonJanice S Ellis
Aug 4, 2007·American Journal of Hematology·Suradej HongengSurapol Issaragisil
Oct 20, 2007·European Journal of Cancer Care·G LarssonP-O Sjödén
Nov 1, 2007·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Richard H OsbornePhoebe Joy Ho
Nov 13, 2007·Hemoglobin·Mehrnoosh KosaryanMehdi Ahangari
Nov 28, 2007·Blood Reviews·Guido Lucarelli, Javid Gaziev
Apr 29, 2008·Current Medical Research and Opinion·J KarnonR Akehurst
May 23, 2008·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Vijj KasemsupRonald S Hadsall
Jun 19, 2008·Bone Marrow Transplantation·D K L CheukG C F Chan
Aug 5, 2009·Antimicrobial Agents and Chemotherapy·Elizabeth C WeissMark S Smeltzer
Feb 26, 2010·BMC Blood Disorders·Montarat ThavorncharoensapBang-On Ubol
Mar 10, 2011·The International Journal of Pharmacy Practice·Arthorn RiewpaiboonPiyanuch Piyauthakit
Feb 15, 2012·Asia-Pacific Journal of Public Health·Yupin JopangFrank Peter Schelp
Citations
Feb 6, 2013·BMC Health Services Research·Rosarin SruamsiriSuradej Hongeng
Mar 20, 2013·Haematologica·Alois GratwohlUNKNOWN Worldwide Network of Blood and Marrow Transplantation (WBMT)
Apr 10, 2014·Journal of the American Medical Informatics Association : JAMIA·Rajat Kumar AgarwalLawrence Faulkner
Aug 3, 2012·Journal of Health Organization and Management·Sripen TantivessYot Teerawattananon
Feb 16, 2016·Bone Marrow Transplantation·U AnurathapanB S Andersson
Apr 5, 2016·Hematology/oncology Clinics of North America·Suthat Fucharoen, David J Weatherall
Apr 5, 2016·Transfusion·Diana WeidlichJulian F Guest
Jun 16, 2012·Blood·Nandita KheraStephanie J Lee
Jan 4, 2018·Blood Advances·Lawrence FaulknerRajat Kumar Agarwal
Jul 26, 2017·Journal of Market Access & Health Policy·Myriam Razgallah KhroufTarek Ben Othman
Sep 8, 2020·Bone Marrow Transplantation·Lawrence FaulknerUNKNOWN Pediatric Diseases Working Party of the European Blood and Marrow Transplantation Group
Oct 29, 2020·Pediatric Transplantation·Venkateswaran Vellaichamy SwaminathanRevathi Raj
Apr 21, 2018·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·M Joseph JohnShankar Prinja